Clinical Trials

Showing trials with last updates posted in 2020.

NCT01704872 | COMPLETED | PHASE1
16 participants

ch14.18/CHO Bridging Study

Study Type:
INTERVENTIONAL
Last Updated:
2020-10-22
Start Date:
2005-07-31
Completion:
2006-02-28
Conditions
  • Neuroblastoma
Interventions
  • DRUG
No Results Yet
NCT01075321 | COMPLETED | PHASE1/PHASE2
58 participants

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2020-10-22
Start Date:
2011-01-10
Completion:
2015-02-28
Conditions
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Angioimmunoblastic T-cell Lymphoma
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Hepatosplenic T-cell Lymphoma
  • Nodal Marginal Zone B-cell Lymphoma
  • Peripheral T-cell Lymphoma
  • Post-transplant Lymphoproliferative Disorder
  • Recurrent Adult Burkitt Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent Adult Hodgkin Lymphoma
  • Recurrent Adult T-cell Leukemia/Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Mycosis Fungoides/Sezary Syndrome
  • Splenic Marginal Zone Lymphoma
  • Waldenstrom Macroglobulinemia
Interventions
  • DRUG
  • OTHER
  • GENETIC
Previous
Sorted by latest updates
Next
Showing 40 trials per page